Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 26, 2023: INO-3107 / HPV-related diseases / Inovio Pharmaceuticals: Positive COMP opinion for Orphan Drug Designation in EU INOVIO announced that the European Committee for Orphan Medicinal […]
Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 26, 2023: Glofitamab (IV) / DLBCL / Roche: Received positive CHMP recommendation for EU approval CHMP has recommended the approval of Columvi for DLBCL after two or […]
Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 26, 2023: Olaparib (IV) / mCRPC/ Merck/ AstraZeneca: FDA questioned on efficacy data from PROpel study FDA debated on briefing documents released ahead of an advisory committee […]
Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 24, 2023: 177Lu-PNT2002 (IV) / Prostate Cancer / Lantheus and POINT Biopharma: Granted fast track designation by US FDA US FDA has granted fast track designation for […]
Weekly Digest – 22-28 Apr 2023 Weekly Digest – 22-28 Apr 2023 April 23, 2023: Darovasertib (oral) and Crizotinib (oral) / Uveal Melanoma / Ideaya: Positive Phase 2 data and successful FDA Type C meeting on registrational trial design Ideaya […]
